Patient Views During the CTV Renaissance

CTV is changing how advertising is targeted, sold, and delivered, but how do patients feel about the new technology? Unlike smartphones and tablets, CTV hasn’t required people to become comfortable with new technology; the ads are delivered on the same TV sets people have known forever. We conducted research exploring whether patients understand that they’re in the middle of a media renaissance and how they feel about it as it pertains to pharma ads.

John Mangano
, DeepIntent’s SVP of Analytics, presents the key findings from this research, with specific insight into:

How patients view pharma ads on linear TV vs. CTV
How valuable they find pharma advertising in general
How their viewing behaviors reflect wider viewing trends

Share this Post

Related Articles

   In this Season 2 kickoff of Deep: The Health Marketing Podcast, healthcare marketing leader John Mangano sits down with Holly Dunn, Managing Partner at Havas Media Network, to explore one of the most pressing issues in healthcare today: how to reach underserved and underrepresented patient populations. Holly shares how systemic gaps in healthcare access, from rural health deserts […]

 In this bonus episode of Deep: The Healthcare Marketing Podcast, host John Mangano sits down with DeepIntent Founder and CEO Chris Paquette for a candid, wide-ranging conversation on the future of healthcare marketing—and what it means to get it right. Chris shares the story of how his unique background led to the creation of DeepIntent. He […]

What’s the secret to improving your reach, optimizing campaign performance, and driving better health outcomes for consumers today? It’s simple: Health IntelligenceTM. By combining real-time data, artificial intelligence (AI), and programmatic advertising, Health Intelligent campaigns deliver more personalized and relevant health engagements with unmatched speed. As we enter a new era of healthcare advertising, Health […]

Never Miss New Insights

Sign up for the newsletter to ensure our latest whitepapers, research reports, and more are delivered to your inbox.